- Home
- SNSE vs AMZE Comparison
SNSE vs AMZE Comparison
Compare SNSE & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- AMZE
- Stock Information
- Founded
- SNSE 2005
- AMZE 2019
- Country
- SNSE United States
- AMZE United States
- Employees
- SNSE N/A
- AMZE N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- AMZE Beverages (Production/Distribution)
- Sector
- SNSE Health Care
- AMZE Consumer Staples
- Exchange
- SNSE Nasdaq
- AMZE Nasdaq
- Market Cap
- SNSE 10.3M
- AMZE 12.3M
- IPO Year
- SNSE 2021
- AMZE 2021
- Fundamental
- Price
- SNSE $8.60
- AMZE $0.47
- Analyst Decision
- SNSE Strong Buy
- AMZE
- Analyst Count
- SNSE 5
- AMZE 0
- Target Price
- SNSE $72.50
- AMZE N/A
- AVG Volume (30 Days)
- SNSE 39.5K
- AMZE 38.2M
- Earning Date
- SNSE 11-14-2025
- AMZE 11-14-2025
- Dividend Yield
- SNSE N/A
- AMZE N/A
- EPS Growth
- SNSE N/A
- AMZE N/A
- EPS
- SNSE N/A
- AMZE N/A
- Revenue
- SNSE N/A
- AMZE $2,245,143.00
- Revenue This Year
- SNSE N/A
- AMZE $6,741.66
- Revenue Next Year
- SNSE N/A
- AMZE $100.61
- P/E Ratio
- SNSE N/A
- AMZE N/A
- Revenue Growth
- SNSE N/A
- AMZE 369.95
- 52 Week Low
- SNSE $5.00
- AMZE $0.24
- 52 Week High
- SNSE $18.35
- AMZE $19.44
- Technical
- Relative Strength Index (RSI)
- SNSE 44.73
- AMZE 37.43
- Support Level
- SNSE $8.37
- AMZE $0.24
- Resistance Level
- SNSE $9.42
- AMZE $0.38
- Average True Range (ATR)
- SNSE 1.08
- AMZE 0.13
- MACD
- SNSE -0.02
- AMZE 0.07
- Stochastic Oscillator
- SNSE 33.45
- AMZE 36.47
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.